ANI Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Hello everybody, I'm E Katerina Niskova from JPMorgan and pleased to be introducing ANI Pharmaceuticals. And from the company we have Nihil Elwani, CEO, and Steve Carey, CFO, who will be doing a presentation, and then we will jump into Q&A.
And with that I will turn over to Nihil.
Thank you.
Good afternoon and thank you for joining us here for a session on ANI Pharmaceuticals.
These are our standard disclaimers regarding forward-looking statements and of the financial information that we're presenting.
So, I'm proud to tell you here about ANI Pharmaceuticals, a profitable, high-growth biopharmaceutical organization that we're transforming into a leading rare disease company. As we go through the presentation, I'll tell you about how we're accelerating this transformation into a leading rare disease company.
In 206, we're projecting over a billion dollars of revenue,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
